NEXTGEN HEALTHCARE, INC. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022	FY2021 12 months to Mar 31, 2021	FY2020 12 months to Mar 31, 2020	FY2019 12 months to Mar 31, 2019
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of capitalized software costs
Amortization and write-off of debt issuance costs
Amortization of other intangibles
Net amortization (accretion) of premiums/discounts on marketable securities
Change in fair value of contingent consideration
Deferred income taxes
Depreciation
Excess tax deficiency (benefit) from share-based compensation
Impairment of assets
Loss on disposal of equipment and improvements
Loss on foreign currency exchange rates
Non-cash operating lease costs
Provision for bad debts
Provision for (recovery of) inventory obsolescence
Restructuring costs, net of amounts paid
Share-based compensation
Gain on disposition of Commercial Dental assets
Changes in assets and liabilities, net of amounts acquired:
Accounts receivable
Contract assets
Inventory
Accounts payable
Contract liabilities
Accrued compensation and related benefits
Income taxes
Deferred compensation
Operating lease liabilities
Other assets and liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Additions to capitalized software costs
Additions to equipment and improvements
Acquisition related working capital adjustment payments
Payments for acquisitions, net of cash acquired
Proceeds from over-funded corporate-owned life insurance policies
Proceeds from disposition of Commercial Dental assets
Proceeds from sales of marketable securities
Purchases of marketable securities
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from convertible senior notes
Proceeds from line of credit
Repayments on line of credit
Payment of debt issuance costs
Proceeds from issuance of shares under employee plans
Repurchase of common stock
Payment of contingent consideration related to acquisitions
Payments for taxes related to net share settlement of equity awards
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period
Supplemental disclosures of cash flow information:
Cash paid for income taxes
Cash refunds from income taxes
Cash paid for interest
Non-cash investing and financing activities:
Non-cash additions to capitalized software
Unrealized gain on marketable securities, net of $0 tax
Cash paid for amounts included in the measurement of operating lease liabilities
Operating lease assets obtained in exchange for operating lease liabilities
Accrued purchases of equipment and improvements

Comments